Neonatal insulin secretion: implications for the programming of metabolic homeostasis. 1997

A Aynsley-Green, and J M Hawdon, and S Deshpande, and M W Platt, and K Lindley, and A Lucas
Institute of Child Health, London, United Kingdom.

Patterns of metabolic adaptation are described in the neonate, which generate two fundamental concepts. First, that early nutritional experiences may have long-term effects on the control of metabolic homeostasis, and second, that insulin has a fundamental role in this process. The endocrine pancreas in the neonate is unable to regulate insulin secretion in relation to blood glucose concentration with the same level of tight control seen in the older child and adult. Moreover, the pattern of metabolic adaptation in the fullterm infant in the first postnatal week is different to that of the preterm baby and the infant born small-for-gestational-age (SGA), with both preterm and SGA infants being unable to generate counter-regulatory ketogenesis as blood glucose concentrations fall. The inability to initiate ketogenesis and switch off insulin secretion after birth persists for several weeks in preterm infants. Methods of feeding term and preterm infants have profound effects on the neonatal endocrine milieu and it is suggested that patterns of insulin secretion provoked in the newborn period may 'programme' the subsequent development of metabolic control. The recently described molecular mechanisms that underlie the pathogenesis of abnormal insulin secretion in the syndrome of persistent hyperinsulinaemic hypoglycemia of infancy (or pancreatic nesidioblastosis) may offer insights into how such programming may occur.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D006706 Homeostasis The processes whereby the internal environment of an organism tends to remain balanced and stable. Autoregulation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000078790 Insulin Secretion Production and release of insulin from PANCREATIC BETA CELLS that primarily occurs in response to elevated BLOOD GLUCOSE levels. Secretion, Insulin
D000222 Adaptation, Physiological The non-genetic biological changes of an organism in response to challenges in its ENVIRONMENT. Adaptation, Physiologic,Adaptations, Physiologic,Adaptations, Physiological,Adaptive Plasticity,Phenotypic Plasticity,Physiological Adaptation,Physiologic Adaptation,Physiologic Adaptations,Physiological Adaptations,Plasticity, Adaptive,Plasticity, Phenotypic
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age

Related Publications

A Aynsley-Green, and J M Hawdon, and S Deshpande, and M W Platt, and K Lindley, and A Lucas
October 2012, Diabetes, obesity & metabolism,
A Aynsley-Green, and J M Hawdon, and S Deshpande, and M W Platt, and K Lindley, and A Lucas
January 2003, Diabetes technology & therapeutics,
A Aynsley-Green, and J M Hawdon, and S Deshpande, and M W Platt, and K Lindley, and A Lucas
September 2012, Arteriosclerosis, thrombosis, and vascular biology,
A Aynsley-Green, and J M Hawdon, and S Deshpande, and M W Platt, and K Lindley, and A Lucas
March 2015, American journal of physiology. Endocrinology and metabolism,
A Aynsley-Green, and J M Hawdon, and S Deshpande, and M W Platt, and K Lindley, and A Lucas
July 2018, EBioMedicine,
A Aynsley-Green, and J M Hawdon, and S Deshpande, and M W Platt, and K Lindley, and A Lucas
December 1980, Pediatric research,
A Aynsley-Green, and J M Hawdon, and S Deshpande, and M W Platt, and K Lindley, and A Lucas
June 2007, Reviews in endocrine & metabolic disorders,
A Aynsley-Green, and J M Hawdon, and S Deshpande, and M W Platt, and K Lindley, and A Lucas
December 2013, Journal of applied physiology (Bethesda, Md. : 1985),
A Aynsley-Green, and J M Hawdon, and S Deshpande, and M W Platt, and K Lindley, and A Lucas
December 2002, The Journal of endocrinology,
A Aynsley-Green, and J M Hawdon, and S Deshpande, and M W Platt, and K Lindley, and A Lucas
October 2003, Endocrinology,
Copied contents to your clipboard!